Login Register
English
0

Cart

$ 0

The Ibr‐7 derivative of ibrutinib exhibits enhanced cytotoxicity against non‐small cell lung cancer cells via targeting of mTORC 1/S6 signaling(A21010-5.17)

Date:2021-03-16 Views:3